Nephrol Dial Transplant (2002) 17: 2189-2195
© 2002 European Renal Association-European Dialysis and Transplant Association
Superior antimicrobial activity of trisodium citrate over heparin for catheter locking
1 Department of Nephrology and 2 Department of Medical Microbiology and Infection Control, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Background. Haemodialysis catheters used for vascular access are frequently complicated by infection and catheter-related thrombosis. Improvement of interdialytic locking solutions could reduce these problems. Trisodium citrate (TSC) has been advocated in recent years because it might have antimicrobial qualities.
Methods. Antimicrobial efficacy of four concentrations of TSC (2.2, 7.5, 15 and 30%) was compared with three equi-osmolal sodium chloride (NaCl) concentrations, unfractionated heparin 5000 IU/ml and a solution of gentamicin 1 mg/ml in TSC 7.5%. We analysed antimicrobial properties by two classical in vitro susceptibility tests. All tests were performed in triplicate by incubation of test fluids with Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa and Candida albicans.
Results. Increasing TSC concentrations effectively killed the staphylococcal strains in both assays. For E.coli and P.aeruginosa complete killing was achieved only with TSC 30%. TSC 30% was also the only solution that significantly inhibited growth of C.albicans. Heparin manifested no antimicrobial effect of any significance. Adding gentamicin to TSC provided superior bacterial growth inhibition but had no effect on yeast growth. TSC solutions manifested superior antimicrobial activity compared with iso-osmolal NaCl solutions in both assays.
Conclusion. This in vitro study demonstrates superior antimicrobial activity of TSC, especially in higher concentrations, in contrast to heparin. The mechanism seems to differ from hyperosmolality. Ca2+ and Mg2+ chelating effects are probably more important. Adding gentamicin provided the most potent antimicrobial solution. However, for reasons concerning development of bacterial resistance and sensitization of the patient, continuous exposition to aminoglycosides seems not advisable.
Keywords: bacteraemia; catheter; haemodialysis; heparin; trisodium citrate; vascular access
Correspondence and offprint requests to: M. C. Weijmer, Department of Nephrology, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. Email: mc.weijmer{at}vumc.nl
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Balestrino, B. Souweine, N. Charbonnel, A. Lautrette, C. Aumeran, O. Traore, and C. Forestier Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3204 - 3209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steczko, S. R. Ash, D. E. Nivens, L. Brewer, and R. K. Winger Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens) Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1937 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sauer, J. Steczko, and S. R. Ash Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions J. Antimicrob. Chemother., May 1, 2009; 63(5): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Winnett, J. Nolan, M. Miller, and N. Ashman Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3592 - 3598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Allon Current Management of Vascular Access Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 786 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Lok, D. Appleton, C. Bhola, B. Khoo, and R. M. A. Richardson Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters Nephrol. Dial. Transplant., February 1, 2007; 22(2): 477 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Q. Shanks, J. L. Sargent, R. M. Martinez, M. L. Graber, and G. A. O'Toole Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2247 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Doorenbos, M. Van den Elsen-Hutten, M. J. M. Heuven, and J. Hessels Estimation of trisodium citrate (Citra-LockTM) remaining in central venous catheters after the interdialytic interval Nephrol. Dial. Transplant., February 1, 2006; 21(2): 543 - 545. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Weijmer, M. A. van den Dorpel, P. J.G. Van de Ven, P. M. ter Wee, J. A.C.A. van Geelen, J. O. Groeneveld, B. C. van Jaarsveld, M. G. Koopmans, C. Y. le Poole, A. M. Schrander-Van der Meer, et al. Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2769 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. H. Betjes and M. van Agteren Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1546 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Weijmer, M. G. Vervloet, and P. M. ter Wee Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use Nephrol. Dial. Transplant., March 1, 2004; 19(3): 670 - 677. [Abstract] [Full Text] [PDF]
|
|